About Partillion
Partillion is a company based in Los Angeles (United States) founded in 2020. Partillion has raised $9.87 million across 8 funding rounds from investors including HHS, ND Capital and Vertical Venture Partners. The company has 15 employees. Partillion offers products and services including Antibody Discovery Kits, Biotinylated Nanovials, and Custom and Bulk Orders. Partillion operates in a competitive market with competitors including RoosterBio, Prolific Machines, Hangzhou Aiming Medical Technology, Biologos and Cell Systems, among others.
- Headquarter Los Angeles, United States
- Employees 15
- SectorsHealthcare
- Email••••••••
- Website partillion.com
- Social LinkedIn X
- Legal Name Partillion Bioscience Corporation
- Total Equity Funding$9.87M (USD)
in 8 rounds
- Latest Funding Round$5M (USD), Seed
Sep 2023
- InvestorsHHS
& 3 more
- Employee Count15
Products & Services of Partillion
Partillion offers a comprehensive portfolio of products and services, including Antibody Discovery Kits, Biotinylated Nanovials, and Custom and Bulk Orders.
Kits for discovering antibodies in single-cell assays
Reagents for functional single-cell biology research
Services for customized biotechnology products and orders
Funding Insights of Partillion
Partillion has successfully raised a total of $9.87M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $5 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.87M
- Total Rounds 8
- Last Round Seed — $5M
- First Round $219,679
(May 2021)
- Investors Count 4
All 8 funding rounds of Partillion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $5M | Seed | – | – | |
| Sep 2023 | $1.5M | Grant | – | – | |
| Aug 2023 | $275,489 | Grant | – | – | |
| Dec 2022 | $4.87M | Seed | – | – | – |
| Sep 2021 | $1.85M | Grant | – | – | |
| Sep 2021 | $255,916 | Grant | – | – | |
| Jun 2021 | $236,407 | Grant | – | – | |
| May 2021 | $219,679 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Partillion
Partillion has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, ND Capital and Vertical Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech startups are invested in by this venture capital firm. | – | nd.capital | Woodside, United States | |
Early-stage venture capital investments are made in specific industry verticals. | – | vvp.vc | Palo Alto, United States | |
Venture capital is invested in multiple sectors by Paladin Capital. | – | paladincapgroup.com | Washington, Dc, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Partillion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Partillion
6 people are tracked at Partillion (4 in leadership, 2 in team); the tracked headcount is 15.
| Name | Role | Group |
|---|---|---|
Joe de Rutte | Co-Founder and CEO | Leadership |
Jesse Liang | Associate Director Of R&d | Leadership |
Brad Crutchfield | Director | Leadership |
Fernando S. | Global Business Development Director | Leadership |
Michael Bogumil | Graduate Engineering Intern | Team |
Priscilla Yang | Magnify Intern | Team |
Complete people profiles for Partillion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Partillion
3 dated milestones of Partillion across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Partillion is founded.
- Funding First funding round of $220K.
- Funding Latest funding round, Seed, of $5.0M.
Competitors of Partillion
Partillion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RoosterBio, Prolific Machines, Hangzhou Aiming Medical Technology, Biologos and Cell Systems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| prolific-machines.com | 2020 | United States | $55M | – | Photomolecular biology platform is provided for controlling cellular functions dynamically. | |
| aimingmed.com | 2020 | Hangzhou, China | – | – | Life sciences reagents, instruments, and services are supplied. | |
| biologos.com | 1976 | Chicago, United States | – | 26 | Custom biologics are manufactured for research applications. | |
| cell-systems.com | 1989 | Kirkland, United States | $200,000 | – | Primary cells, culture media, and reagents are developed and manufactured. | |
| xcell.co.kr | 2015 | Seoul, South Korea | – | – | Serum-free media for MSC cell culture is developed and provided. | |
| cellntec.com | 2001 | Bern, Switzerland | – | – | Cell culture media and models for epithelial cells are developed. | |
| purcell-bio.com | 2020 | Bozeman, United States | $841,000 | – | Developer of cell culture media for research purpose | |
| bionutrientes.com.br | 2001 | Sao Paulo, Brazil | – | – | Manufacturer of animal serum for vaccine production |
Detailed competitors of Partillion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Partillion
The website of Partillion (partillion.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 15.8% vs previous month
Latest news on Partillion
Complete news archive for Partillion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Partillion
10 companies that operate in the same segment as Partillion (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Partillion
Partillion was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Partillion is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Partillion is a funded company, having raised a total of $9.87M across 8 funding rounds to date. The company's 1st funding round was a Grant of $219.68K, raised on May 2021.
Partillion has 15 employees.
Partillion was founded in 2020 in Los Angeles, United States, within the biotechnology sector. Single-cell assays are developed to support cell analysis operations. A nanovial platform is employed for the rapid compartmentalization and examination of millions of single cells. Biological functions, including secreted proteins, are investigated through these methods. The companys activities center on enhancing assay capabilities for research applications.
Partillion's top competitors include RoosterBio, Prolific Machines and Xcell Therapeutics.
Partillion offers Antibody Discovery Kits, Biotinylated Nanovials, and Custom and Bulk Orders.
Partillion has 4 investors. Key investors include HHS, ND Capital, Vertical Venture Partners, and Paladin Capital.
Partillion operates through Partillion Bioscience Corporation.